Market psychology is amazing. Most that know of the potential of the company are already in, but many will remain on the sidelines understanding what a 1-2 billion market cap would do to the share price upon fantastic results while still hoping to get in on a successful top line result PR in the 10 to 15 dollar range. That would be comparable to what we saw with AXSM with their P2 back in the day. Would still be huge upside but with almost zero risk playing it that way.
What happened with our first trial is the company came out with the compassionate use patient details at an investor conference and all the sudden an 8 dollar stock surges to 30 bucks in a few weeks with so many people chasing the stock. I'm hopeful that the company gains bioequivalence and announces in the next month or so and a similar reaction takes place....not so I could sell, but so the share price will be as high as possible when they do eventually raise money for additional trials. Either way, 8 weeks or so until results.
News 
Market Data 
Discover 
AI
